Category: European Union
-
Novo Nordisk lets key Ozempic patent lapse in Canada, despite being worldâs second-largest semaglutide market
Novo Nordisk has continued to pay for a key Ozempic patent in several jurisdictions across the world, and even obtained an adjusted expiration date in the U.S., but the company stopped paying fees in Canada as far back as 2018, records show.
-
Standardization âindispensableâ in making Europe the âquantum continentâ: ETSI responds to proposed EU quantum strategy
ETSI is among 168 respondents to the EUâs call for evidence on its incoming Quantum Strategy, which is aiming to make Europe take the lead in the global quantum race, with some stating that enhancing IP commercialisation mechanisms will also be key.